RodrÃguez, F.; Caruana, P.; De la Fuente, N.; Español, P.; Gámez, M.; Balart, J.; Llurba, E.; Rovira, R.; Ruiz, R.; MartÃn-Lorente, C.;
et al. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules 2022, 12, 784.
https://doi.org/10.3390/biom12060784
AMA Style
RodrÃguez F, Caruana P, De la Fuente N, Español P, Gámez M, Balart J, Llurba E, Rovira R, Ruiz R, MartÃn-Lorente C,
et al. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules. 2022; 12(6):784.
https://doi.org/10.3390/biom12060784
Chicago/Turabian Style
RodrÃguez, Francisco, Pablo Caruana, Noa De la Fuente, PÃa Español, MarÃa Gámez, Josep Balart, Elisa Llurba, Ramón Rovira, Raúl Ruiz, Cristina MartÃn-Lorente,
and et al. 2022. "Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges" Biomolecules 12, no. 6: 784.
https://doi.org/10.3390/biom12060784
APA Style
RodrÃguez, F., Caruana, P., De la Fuente, N., Español, P., Gámez, M., Balart, J., Llurba, E., Rovira, R., Ruiz, R., MartÃn-Lorente, C., Corchero, J. L., & Céspedes, M. V.
(2022). Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules, 12(6), 784.
https://doi.org/10.3390/biom12060784